125 related articles for article (PubMed ID: 33589316)
21. Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research Network.
Griffith DC; Farmer C; Gebo KA; Berry SA; Aberg J; Moore RD; Gaur AH; Mathews WC; Beil R; Korthuis PT; Nijhawan AE; Rutstein RM; Agwu AL;
HIV Med; 2019 Feb; 20(2):169-174. PubMed ID: 30561888
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population.
Priest J; Bhak RH; Dersarkissian M; Oglesby A; Kunzweiler C; Fuqua E; Park S; Duh MS; Garris C
J Med Econ; 2021; 24(1):1204-1211. PubMed ID: 34665994
[TBL] [Abstract][Full Text] [Related]
23. Adherence to HIV treatment regimens: systematic literature review and meta-analysis.
Altice F; Evuarherhe O; Shina S; Carter G; Beaubrun AC
Patient Prefer Adherence; 2019; 13():475-490. PubMed ID: 31040651
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
Cotte L; Ferry T; Pugliese P; Valantin MA; Allavena C; Cabié A; Poizot-Martin I; Rey D; Duvivier C; Cheret A; Dellamonica P; Pradat P; Parienti JJ;
PLoS One; 2017; 12(2):e0170661. PubMed ID: 28152047
[TBL] [Abstract][Full Text] [Related]
25. Which antiretroviral regimen is associated with higher adherence in Brazil? A comparison of single, multi, and dolutegravir-based regimens.
Cardoso TS; Costa JO; Reis EA; Silveira MR; Bonolo PF; Santos SFD; Ceccato MDGB
Cad Saude Publica; 2019 Sep; 35(9):e00115518. PubMed ID: 31531518
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral therapy adherence among treatment-naive HIV-infected patients.
Chakraborty A; Qato DM; Awadalla SS; Hershow RC; Dworkin MS
AIDS; 2020 Jan; 34(1):127-137. PubMed ID: 31567165
[TBL] [Abstract][Full Text] [Related]
27. Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan.
Wang X; Schmerold L; Naito T
J Infect Chemother; 2022 Nov; 28(11):1464-1470. PubMed ID: 35850403
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients.
Merker A; Badowski M; Chiampas T; Pérez SE; Patel M; Young J; Werner R
J Correct Health Care; 2018 Jan; 24(1):52-61. PubMed ID: 29239232
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of antiretroviral therapy in individuals who for economic reasons were switched from a once-daily single-tablet regimen to a triple-tablet regimen.
Engsig FN; Gerstoft J; Helleberg M; Nielsen LN; Kronborg G; Mathiesen LR; Obel N
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):407-13. PubMed ID: 24984188
[TBL] [Abstract][Full Text] [Related]
30. Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims.
Malinverni S; Bédoret F; Bartiaux M; Gilles C; De Wit S; Libois A
Sex Transm Infect; 2021 Aug; 97(5):329-333. PubMed ID: 33106437
[TBL] [Abstract][Full Text] [Related]
31. Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.
Fabbiani M; Zaccarelli M; Latini A; Sterrantino G; D'Ettorre G; Grima P; Mondi A; Rossetti B; Borchi B; Giuliani M; Antinori A; De Luca A; Di Giambenedetto S
HIV Med; 2016 May; 17(5):385-9. PubMed ID: 26394902
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhibitor-containing first-line antiretroviral therapy in Pune, India.
Dravid A; Betha TP; Sharma AK; Gawali R; Mahajan U; Kulkarni M; Saraf C; Kore S; Dravid M; Rathod N
HIV Med; 2020 Oct; 21(9):578-587. PubMed ID: 33021066
[TBL] [Abstract][Full Text] [Related]
33. Barriers to HIV Medication Adherence as a Function of Regimen Simplification.
Chen Y; Chen K; Kalichman SC
Ann Behav Med; 2017 Feb; 51(1):67-78. PubMed ID: 27510955
[TBL] [Abstract][Full Text] [Related]
34. Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis.
Michienzi SM; Schriever CA; Badowski ME
Int J STD AIDS; 2019 Feb; 30(2):181-187. PubMed ID: 30381029
[TBL] [Abstract][Full Text] [Related]
35. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
Langness J; Cook PF; Gill J; Boggs R; Netsanet N
J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
[TBL] [Abstract][Full Text] [Related]
36. HIV Clinical Updates: New Single-Tablet Regimens.
Sebaaly JC; Kelley D
Ann Pharmacother; 2019 Jan; 53(1):82-94. PubMed ID: 30073873
[TBL] [Abstract][Full Text] [Related]
37. Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy.
Jiménez-Galán R; Cantudo Cuenca MR; Robustillo-Cortés MA; Borrego Izquierdo Y; Almeida-Gonzalez CV; Morillo-Verdugo R
Farm Hosp; 2016 Jun; 40(4):272-8. PubMed ID: 27571495
[TBL] [Abstract][Full Text] [Related]
38. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.
Hanna DB; Hessol NA; Golub ET; Cocohoba JM; Cohen MH; Levine AM; Wilson TE; Young M; Anastos K; Kaplan RC
J Acquir Immune Defic Syndr; 2014 Apr; 65(5):587-96. PubMed ID: 24326606
[TBL] [Abstract][Full Text] [Related]
39. Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide.
Chow W; Donga P; Côté-Sergent A; Rossi C; Lefebvre P; Lafeuille MH; Hardy H; Emond B
Patient Prefer Adherence; 2020; 14():2315-2326. PubMed ID: 33262581
[TBL] [Abstract][Full Text] [Related]
40. Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting.
Chang HM; Chou CH; Tsai HC
BMC Infect Dis; 2022 Jan; 22(1):2. PubMed ID: 34983388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
